18.0% CAGR of growth in the Microbiome Sequencing Services Market during the forecast period, 2018 to 2023|Key Vendors - CLINICAL MICROBIOMICS A/S, BASECLEAR B.V., METABIOMICS CORP., MICROBIOME INSIGHTS INC., UBIOME, INC., among others

Market Analysis:

North America to Dominate the Market
North America dominates the market, owing to factors, such as government support through funds for genomics research, consistent developments in sequencing technologies, and ease in availability of commercial solutions for NGS data analysis. Asia-Pacific is also expected to grow tremendously during the forecast period, owing to growing number of research studies on cancer and inherited rare diseases, and rising demand for next-generation sequencing for diagnosis and therapeutic applications.

Detailed Sample Copy of Updated Analysis @ https://marketprognosis.com/sample-request/16754
Note: “If this link doesn’t work in Internet Explorer, kindly try pasting it in other browsers.”

The sequencing of metagenome offers a novel method in diagnosing and treating a wide range of chronic diseases, such as oncology, etc. Rising demand for NGS, surge in genomic research, and widening application area of microbiome sequencing, and a decline in the cost of sequencing are the major factors driving the growth of the market. Lack of technicians in the interpretation of sequencing data is the major factor restricting the growth of the market. Further, government regulations and ethical & legal issues related to NGS are the also restraining the growth of the microbiome sequencing services market.

Request Discount on this report @ https://marketprognosis.com/discount-request/16754
Note: “If this link doesn’t work in Internet Explorer, kindly try pasting it in other browsers.”

Market Segments
Microbiome Sequencing Services Market is segmented by:
1. Technology: Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), Short Gun Sequencing, Targeted Gene Sequencing, RNA Sequencing, Others
2. Application: Gastro-Intestinal Diseases, Infectious Diseases, CNS Diseases, Oncology, Others
3. End User: Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, Others
4. Geography: North America, South America, Europe, Asia Pacific, Middle East & Africa

Key Developments in the Market
• November 2017: MicroBiome Therapeutics, LLC launched first microbiome modulator. The product is described as an all-natural blend of prebiotics, including fermentable fiber and polyphenol antioxidants, in a patent-pending blend intended to help nurture and nourish beneficial microorganisms in the lower gut.
• June 2017: Zymo Research Corp. launched new kits for Microbiome Research at ASM Microbe 2017.

Enquiry Before Buying @ https://marketprognosis.com/enquiry/16754
Note: “If this link doesn’t work in Internet Explorer, kindly try pasting it in other browsers.”

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMarkPvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.